Barrea Luigi, Verde Ludovica, Savastano Silvia, Colao Annamaria, Muscogiuri Giovanna
Dipartimento di Scienze Umanistiche, Università Telematica Pegaso, Centro Direzionale Isola F2, Via Porzio, 80143 Naples, Italy.
Centro Italiano per la cura e il Benessere del Paziente con Obesità (C.I.B.O), Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
Antioxidants (Basel). 2023 Jun 21;12(7):1318. doi: 10.3390/antiox12071318.
Oxidative stress is considered one of the main determinants in the pathophysiology of non-alcoholic fatty liver disease (NAFLD) and obesity. The alterations of oxidant/antioxidant balance are related to chronic impairment of metabolism leading to mitochondrial dysfunction. Increased oxidative stress also triggers hepatocytes stress pathways, leading to inflammation and contributing to the progression of non-alcoholic steatohepatitis (NASH). Currently, the first-line therapeutic treatment of NAFLD is based on lifestyle interventions, suggesting the Mediterranean Diet (MD) as a preferable nutritional approach due to its antioxidant properties. However, it is still debated if adherence to MD could have a role in determining the risk of developing NAFLD directly or indirectly through its effect on weight. We enrolled 336 subjects (aged 35.87 ± 10.37 years; BMI 31.18 ± 9.66 kg/m) assessing anthropometric parameters, lifestyle habits, metabolic parameters (fasting plasma glucose, fasting plasma insulin, triglycerides (TG), total cholesterol, low-density (LDL) and high-density lipoprotein (HDL) cholesterol, alanine transaminase (ALT), aspartate aminotransferase (AST), and γ-glutamyltransferase (γGT), cardio-metabolic indices [Homeostatic Model Assessment Insulin Resistance (HoMA-IR), visceral adipose index (VAI) and fatty liver index (FLI)] and adherence to MD [with the PREvención con DIetaMEDiterránea (PREDIMED) questionnaire]. Subjects with NAFLD had significantly higher anthropometric parameters, cardio-metabolic indices and lower adherence to MD than subjects without NAFLD. In a multiple regression analysis, PREDIMED score was the main predictor of FLI ( < 0.001) and came in first, followed by HoMA-IR, while VAI was not a predictor. A PREDIMED score value of <6 could serve as a threshold to identify patients who are more likely to have NAFLD ( < 0.001). In conclusion, high adherence to MD resulted in a lower risk of having NAFLD. Adherence to MD could have a direct role on the risk of developing NAFLD, regardless of visceral adipose tissue.
氧化应激被认为是非酒精性脂肪性肝病(NAFLD)和肥胖病理生理学的主要决定因素之一。氧化剂/抗氧化剂平衡的改变与导致线粒体功能障碍的慢性代谢损伤有关。氧化应激增加还会触发肝细胞应激途径,导致炎症并促进非酒精性脂肪性肝炎(NASH)的进展。目前,NAFLD的一线治疗基于生活方式干预,由于其抗氧化特性,建议采用地中海饮食(MD)作为首选的营养方法。然而,坚持MD是否能直接或通过其对体重的影响间接影响患NAFLD的风险仍存在争议。我们招募了336名受试者(年龄35.87±10.37岁;BMI 31.18±9.66kg/m),评估人体测量参数、生活习惯、代谢参数(空腹血糖、空腹血浆胰岛素、甘油三酯(TG)、总胆固醇、低密度(LDL)和高密度脂蛋白(HDL)胆固醇、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)和γ-谷氨酰转移酶(γGT))、心脏代谢指标[稳态模型评估胰岛素抵抗(HoMA-IR)、内脏脂肪指数(VAI)和脂肪肝指数(FLI)]以及对MD的依从性[采用地中海饮食预防(PREDIMED)问卷]。与无NAFLD的受试者相比,患有NAFLD的受试者人体测量参数、心脏代谢指标显著更高,对MD的依从性更低。在多元回归分析中,PREDIMED评分是FLI的主要预测因子(<0.001)且排名第一,其次是HoMA-IR,而VAI不是预测因子。PREDIMED评分值<6可作为识别更易患NAFLD患者的阈值(<0.001)。总之,高度坚持MD可降低患NAFLD的风险。坚持MD可能对患NAFLD的风险有直接影响,而与内脏脂肪组织无关。